DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ctnc2j/global_obesity) has announced the addition of the "Global Obesity Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Obesity epidemiology, Obesity diagnosed patients, and Obesity treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Obesity derived from epidemiological analysis, percentage of patients diagnosed with Obesity, and percentage of patients treated with Obesity therapy.
The study helps executives estimate Obesity market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Obesity prevalence, Obesity diagnosis rate, and Obesity treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Obesity: Disease Definition
2. Global Obesity Patient Flow
3. Obesity Patient Flow in the US
4. Obesity Patient Flow in Europe
5. Obesity Patient Flow in Germany
6. Obesity Patient Flow in France
7. Obesity Patient Flow in Spain
8. Obesity Patient Flow in Italy
9. Obesity Patient Flow in UK
10. Obesity Patient Flow in Japan
For more information visit http://www.researchandmarkets.com/research/ctnc2j/global_obesity